Percheron Therapeutics LimitedASX: PER

ANP initiates ATL1102 Phase II clinical trial in DMD

Jul 16, 2018 at 3:56 AM UTC · Issued by Percheron Therapeutics Limited

Percheron Therapeutics Limited has released a press release.

View Attachment